Search - tctmd.com

Displaying 721 - 740 of 1856

Sort: Relevancy | Date

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Opinion Fellow Talk

Why All Interventionalists Should Be on Twitter

Amit K. Gupta, MBBS, MD

October 18, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Shelley Wood

September 28, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Conference News PCR London Valves 2017

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Shelley Wood

September 24, 2017

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

News Daily News

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

L.A. McKeown

September 07, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

Advertisement

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Why All Interventionalists Should Be on Twitter

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

TCTMD’s Top 10 Most Popular Stories for September 2017

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Valve Deterioration and Durability Definitions Now Standardized in New Guide

TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Conscious Sedation in TAVR Linked to Lower Mortality, Shorter Hospital Stays: TVT Registry

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

TCTMD’s Top 10 Most Popular Stories for August 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content